Jeremy is an oncological surgeon with primary interest in bladder cancer. Previously, he conducted a randomised trial showing that bipolar transurethral resection of bladder tumour (TURBT) was able to achieve a higher detrusor sampling rate than monopolar TURBT. He has also developed a global consensus statement on en bloc resection of bladder tumour (ERBT). The consensus statement has become the standard reference for urologists practising en bloc resection globally. In 2024, he published the results of the EB-StaR study, which is a multi-centre randomised trial demonstrating that ERBT could reduce the 1-year recurrence rate from 38.1% to 28.5% for patients with ≤3cm non-muscle-invasive bladder cancer (NMIBC). He completed a phase 2 clinical trial on modified en bloc resection for large bladder tumours (>3cm), showing that modified ERBT could achieve a >90% rate of complete resection for NMIBC and proper staging for MIBC. He is also leading the Global ERBT Registry, which has >100 centres joining and >3000 patients being recruited so far. He is currently serving as a panel member of the European Association of Urology (EAU) Guidelines on NMIBC and Upper Tract Urothelial Carcinoma. He is also serving as an Associate Editor for the prestigious journal European Urology Oncology.
Selected publications from PubMed
Individual Patient Data Validation of the EAU Definitions of BCG Failure in Patients with Non-muscle-invasive Urothelial Carcinoma of the Bladder: An International Multicenter Retrospective Study.
Gontero P, Soria F, Babjuk M, Burger M, Palou Redorta J, D'Andrea D, Pradere B, Moschini M, Birtle A, Compérat EM, Dominguez-Escrig JL, Liedberg F, Mariappan P, van Rhijn BWG, Seisen T, Shariat SF, Teoh J, Xylinas E, Capoun O, Rai BP, Soukup V, Faba OR, Cohen D, Foster L, Beaud N, Girtner F, Breyer J, Hornak J, Einerhand SMH, Anract J, Bobjer J, Linares E, Rodriguez-Serranos A, Cathomas R, Saba K, Hernandez V, Lorente C, Rouanne M, Lebret T, Masson-Lecomte A, Rouprêt M, Sylvester RJ
Eur Urol Oncol. 2026 Aug;9(4):868-882 doi: 10.1016/j.euo.2026.05.005.
Discordant Response in Pelvic Lymph Nodes and Cystectomy Specimens After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.
Antonelli L, Afferi L, Del Giudice F, Bologna E, Esperto F, Chierigo F, Antonelli A, Tully K, Umari P, Albisinni S, Mari A, Pichler R, Claps F, Teoh JY, Roumiguié M, Schulz GB, Orecchia L, Soria F, Roupret M, Marcq G, Poyet C, Kulkarni GS, Rink M, Klatte T, Campi R, Krajewski W, Mertens L, Culpan M, Lavallée LT, Moschini M, Fankhauser CD, EAU YAU urothelial carcinoma working group
Eur Urol Focus. 2026 Jul 28 pii: S2405-4569(26)00155-0. doi: 10.1016/j.euf.2026.07.009.
EAU Guidelines on Nonmuscle-invasive Bladder Cancer (TaT1 and CIS) - A Summary of the 2026 Guidelines Update.
Gontero P, Mariappan P, Pradere B, Rai BP, Liedberg F, Compérat E, Teoh JY, Moschini M, Soria F, van Rhijn BWG, Baard J, Birtle A, Botha M, Capoun O, D'Andrea D, Fiorini E, Masson-Lecomte A, Seisen T, Shariat SF, Smith EJ, Soukup V, Wood R, Xylinas EN, Dominguez-Escrig JL
Eur Urol. 2026 Jul 15 pii: S0302-2838(26)02111-1. doi: 10.1016/j.eururo.2026.04.009.
Diagnostic Accuracy of Liquid-Based Biomarkers for Detecting and Risk Stratifying Upper Tract Urothelial Cancers: A Diagnostic Test Systematic Review by the EAU Guidelines UTUC Panel.
Rai BP, Rajan K, Rajan P, Pradere B, Capoun O, Soukup V, Gontero P, Soria F, Birtle A, Compérat EM, Dominguez-Escrig JL, Yuan Y, Liedberg F, Rouprêt M, Seisen T, Teoh JY, Moschini M, Mariappan P, Shariat SF, Xylinas E, Baard J, D'Andrea D, van Rhijn BWG, Masson-Lecomte A
Eur Urol Oncol. 2026 Jun;9(3):535-554 doi: 10.1016/j.euo.2026.04.011.
Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-up.
Contieri R, Martini A, Furrer M, D'Andrea D, Claps F, von Deimling M, Soria F, Mari A, Bianchi L, Tonin E, Flippot R, Teoh JYC, Marcq G, Desprez PE, Pichler R, Ślusarczyk A, Subiela JD, Del Giudice F, Santarelli V, Porreca A, Amodeo A, Pavan N, Simonato A, Scilipoti P, Perdonà S, Gontero P, van Rhijn BW, Hurle R, Moschini M, Pradere B, Mertens LS, European Association of Urology‐Young Academic Urologists (EAU‐YAU), Urothelial Carcinoma Working Group
BJU Int. 2026 Jun;137(6):1058-1066 doi: 10.1111/bju.70232.
A surgical perspective on minimizing NMIBC recurrence. Dr. Teoh addresses the limitations of conventional TURBT and discusses the integration of 4K imaging and bipolar plasma energy platforms to facilitate en-bloc resection (ERBT). The lecture details step-by-step techniques for mucosal incision and blunt dissection down to the detrusor muscle, supported by recent randomized controlled trials and the progress of the global ERBT registry.
With Olympus
Published
Aug 2026
Join leading global experts for an exclusive scientific program dedicated to optimizing clinical outcomes in Non-Muscle-Invasive Bladder Cancer (NMIBC). This specialized session will delve into the latest guidelines, visual detection advancements like NBI and PDD, and future strategies to prevent recurrence. Don't miss this opportunity to gain valuable insights from international key opinion leaders, explore precision treatment pathways, and participate in an interactive panel discussion designed to elevate patient care standards.
With Olympus
Published
Jun 2026
Help your network discover Dr. Jeremy Teoh's clinical expertise.
